FKnol.com

Financial Knowledge & Information Portal

Best Performing Biotech Stocks of 2019

Updated Mar 8, 2019
Biotech, or biotechnology, is defined as the exploitation and use of biological processes for industrial, commercial and other requirements, especially the genetic manipulation of microorganisms for the generation, production and development of medicinal elements like antibiotics and hormones which can be used for therapeutic use. It is the technology that uses biological systems, living organisms or their parts to build and develop different products. The specialized sub-sector falls within the larger health care sector and involves activities like drug development, research, manufacturing and marketing in the field of biotech.
Among the big basket of Biotech stocks, which ones generated the top returns this year? Which of those figured among the winners in the long list of Biotech stocks?
This article provides a list of Biotech stocks which have generated the highest returns in the year 2019 so far. till date of writing. The list is prepared based on the percentage returns generated by the individual Biotech stocks between the end of the previous year and Mar 8, 2019, and the top 10 return generating Biotech stocks are listed below.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Biotech Stocks With Highest Returns

Top 10 Biotech Stocks All Biotech Stocks All Biotech ETFs Top Dividend-paying Biotech Stocks
The following list presents stocks of the companies which belong to the broader Biotech sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized:
 1) Bioblast Pharma Ltd. (ORPN) 2) Immune Design Corp. (IMDZ) 3) PLx Pharma Inc. (PLXP) 4) Axsome Therapeutics, Inc. (AXSM) 5) Trevena, Inc. (TRVN)
 6) Spark Therapeutics, Inc. (ONCE) 7) Magenta Therapeutics, Inc. (MGTA) 8) Midatech Pharma PLC (MTP) 9) Genocea Biosciences, Inc. (GNCA) 10) Novus Therapeutics, Inc. (NVUS)
There's more... See price performance, YTD-gains, market-cap and other details of all the 492 Biotech stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Biotech ETFs.
Top 10 Biotech Stocks All Biotech Stocks All Biotech ETFs Top Dividend-paying Biotech Stocks

Performance of Top Biotech Stocks

Here's a look at the basic details and how the above mentioned stocks fared during the period:

Bioblast Pharma

Bio Blast Pharma Ltd. (BioBlast), incorporated on January 22, 2012, is a development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for ... see Detailed Company Profile and Dividend History.
The Israel-based Bioblast Pharma Ltd. (ORPN) belongs to the Health Care sector and is categorized as a Major Pharmaceuticals company. The stock of Bioblast Pharma ended the previous year at a price of $0.77 per share. As of Mar 8, 2019, the stock price has reached $12.6 apiece, which indicates a change of 1536.36 percent making the company rank among the top performing stocks of the Biotech for the year 2019 till date. At the end of the last year, company's market capitalization stood at $2.6 million. It has now changed to $5.29 million as of writing.

Immune Design

Immune Design Corp., a clinical-stage immunotherapy company, engages in the research and development of in vivo treatments for cancer. The company primarily develops oncology product candidates based ... see Detailed Company Profile and Dividend History.
Rank number two in the coveted list is held by Immune Design Corp. (IMDZ) for being among the top performing stocks of 2019. Headquartered in Washington, WA, the Health Care sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2019, stock of Immune Design has so far gained 349.23 percentage, based on the previous year's closing price of $1.3 per share and year-to-date price of $5.84 per share. During the same period, the market capitalization of the company changed from $62.62 million to $282.44 million. The stock of Immune Design continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.

PLx Pharma

PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesics. The company's lead product candidates are Aspertec 81 m ... see Detailed Company Profile and Dividend History.
During the given months of the year 2019, PLx Pharma Inc. (PLXP) was successful in generating YTD returns of 247.71 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2019 till date. As of December of the previous year, the stock of the Houston, TX-based PLx Pharma closed at a price of $1.53 per share, while it traded at a price of $5.32 per share as of Mar 8, 2019. The company's market cap changed from $13.39 million to $46.55 million during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators. The company is classified under the Health Care industry sector and further specialized as a sector business.

Axsome Therapeutics

Axsome Therapeutics, Inc., incorporated on January 12, 2012, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including ... see Detailed Company Profile and Dividend History.
Axsome Therapeutics, Inc. (AXSM) has moved by 241.49 percentage over the given period of 2019-YTD, helping it gain a place at number four among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $2.82 apiece to the price of $9.63 per share between the end of December of the previous year and Mar 8, 2019. The smart run of the New York, NY-based Major Pharmaceuticals sector company lead to a handsome gain in its marketcap which changed from $84.07 million to $287.1 million over the same duration. Axsome Therapeutics is a key member of many popular stock market indexes. They include Wilshire 5000 index, and several other broader level multi-cap market indicators.

Trevena

Trevena Inc., incorporated on November 9, 2007, is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator ... see Detailed Company Profile and Dividend History.
Based on the market-cap change from $35.4 million to $130.18 million during the given months of the year 2019 and the share price change from $0.43 per share to a price of $1.41 per share as of Mar 8, 2019, Trevena, Inc. (TRVN) was successful in generating YTD returns of 227.91 percentage. Standing at the number five rank in the top performing list of Biotech stocks, the Pennsylvania, PA-based Trevena is categorized as the Major Pharmaceuticals sub-sector business which falls under the larger Health Care sector. It is also a part of few famous stock indexes that are used to track the overall performance of the stock market. They include Wilshire 5000 index, and a few more broader-level indexes that are actively tracked in the market.

Spark Therapeutics

Spark Therapeutics, Inc. (Spark), incorporated on March 13, 2013, is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple ... see Detailed Company Profile and Dividend History.
At number six in the list of top stocks stands Spark Therapeutics, Inc. (ONCE), which saw a change in its stock price from the level of $39.14 apiece during previous year December end to the price of $113.79 per share as of Mar 8, 2019. It translates to a change of 190.73 percentage. The Pennsylvania, PA-headquartered Health Care sector company also saw its market value change from $1.48 billion to $4.32 billion. The Biotech Biological Products specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, Russell 2000 index, and a handful of other multi-capitalization indexes.

Magenta Therapeutics

Magenta Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing medicines to bring the curative power of bone marrow transplant to patients. It is developing C100, C200, and C300 t ... see Detailed Company Profile and Dividend History.
Magenta Therapeutics (MGTA) generated percentage returns of 180.7 percent during the 2019 year-to-date. Its returns are based on the share price which moved from $5.7 per share from the previous year-end to the price of $16 per share as of Mar 8, 2019. The company's value, as indicated by the market-cap figure, changed from $188.68 million to $529.64 million during the same period.
The company is categorized as a Health Care speciality business with further classification in the sub-category. Based in Cambridge, MA, the YTD performance of the Biotech sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.

Midatech Pharma

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates throug ... see Detailed Company Profile and Dividend History.
The number eight spot in the list of top performing stocks of the Biotech sector is taken by Midatech Pharma PLC (MTP). The company's stock price changed from $0.15 per share at the end of December of the previous year to the price of $0.41 per share as of writing. Overall, the stock managed to realized price change of 173.4 percent during the given time period. The corresponding change in the market capitalization value of the Abingdon, -based Health Care sector company was from $3.79 million to $30.72 million. Being ranked in the top 10 best performing stocks of the Biotech sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes.

Genocea Biosciences

Genocea Biosciences, Inc., incorporated on August 16, 2006, is harnessing the power of T cell immunity to develop vaccines and immunotherapies. The Company uses its discovery platform, AnTigen Lead Acquisition ... see Detailed Company Profile and Dividend History.
The Massachusetts, MA-headquartered company Genocea Biosciences, Inc. (GNCA) is ranked number nine among the best performing stocks of Biotech of 2019. The Health Care sector business falls under the Biotech Biological Products industrial sub-sector. Since the start of the year 2019, the stock price of Genocea Biosciences has changed by 167.24 percent, which is calculated based on the previous year's closing price of $0.29 per share and year-to-date closing price of $0.78 per share as of writing. The market value of the company as indicated by its market-cap changed from $24.85 million to $87.09 million during the same period. Along with Biotech, the company is also in the business of Health Care, Biotech Biological Products, Biotech Products, Biotechnology, among other usual products and services. Genocea Biosciences continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.

Novus Therapeutics

Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product ... see Detailed Company Profile and Dividend History.
The Irvine, CA-based Health Care sector company Novus Therapeutics, Inc. (NVUS) holds the ten spot among the best performing stocks of the Biotech sector. Classified as the business, the stock price of Novus Therapeutics ended the previous year at a price of $1.6 per share while it reached the level of $4.2 apiece as of Mar 8, 2019 translating to a percentage change in stock price of 162.5%. As of writing, the company's market-cap value stands at $39.57 million. Few leading stock market index includes Novus Therapeutics in their constituent list. They include Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
Popular Investment Lists:

 ◐ Best Performing Meat Stocks of 2019-YTD

 ◐ Best Performing Gaming Stocks of 2019-YTD

 ◐ Best Performing Biofuels Stocks of 2019-YTD

 ◐ Best Performing Software Stocks of 2019-YTD

 ◐ Best Performing China Stocks of 2019-YTD

 ◐ Best Performing Telecom Stocks of 2019-YTD

 ◐ Best Performing Biotech Stocks of 2019-YTD

 ◐ Best Performing Aluminum Stocks of 2019-YTD

 ◐ Best Performing Low Volatility Stocks of 2019-YTD

 ◐ Best Performing REIT Stocks of 2019-YTD

 ◐ Best Performing 5G Stocks of 2019-YTD

 ◐ Best Performing Dogs of the Dow Stocks of 2019-YTD

 ◐ Best Performing Palladium Stocks of 2019-YTD

 ◐ Best Performing Platinum Stocks of 2019-YTD

 ◐ Best Performing Silver Stocks of 2019-YTD

 ◐ Best Performing Gold Stocks of 2019-YTD

 ◐ Best Performing Iron Stocks of 2019-YTD

 ◐ Best Performing Steel Stocks of 2019-YTD

 ◐ Best Performing Dow Jones Stocks of 2019-YTD

 ◐ Best Performing NASDAQ Stocks of 2019-YTD

 ◐ Best Performing S&P 500 Stocks of 2019-YTD

 ◐ Top Companies By Market Value

 ◐ Market Cap of S&P 500 Companies of 2019-YTD

 ◐ See All Common Lists

Search This Site